FROM BENCH TO BOARDROOM - The Scientist’s Guide to Life Science Investment & Strategy (VC, BD, CorpDev)

Master the Business Side of Life Sciences: Your Gateway to VC, Corporate Development & Strategic Roles

Are you a scientist ready to move from the bench to the boardroom? Want to leverage your PhD in venture capital, business development, or corporate strategy... but don't know where to start?

This strategic manual transforms scientists into dealmakers.

What's Inside:

• The BD Ecosystem – understand Search & Evaluation, Transactional BD, Alliance Management, and Commercial Strategy roles (Chapter 1)
• Venture Capital Deep Dive – learn sourcing, due diligence, fund structure, and the path to exit (Chapter 2)
• Corporate Development & M&A – master the "Build, Buy, or Partner" framework and strategic synergies (Chapter 3)
• Boardroom Mathematics – calculate Risk-Adjusted NPV, burn rate, cash runway, and valuation models (Chapter 4)
• Strategic Tools – create Target Product Profiles and conduct technical due diligence like a pro (Chapter 5)
• Professional Branding – optimize your resume, LinkedIn, and networking for strategic roles (Chapter 6)
• Strategic Interviews – ace case studies with the STAR+V method and competitive analysis (Chapter 7)
• 12-Week Action Plan – step-by-step roadmap from financial literacy to investment memos (Chapter 8)
• Career Pathways – understand progression from Associate to Partner across VC, BD, and CorpDev (Chapter 9)
• Insider Realities – learn the unspoken rules of consulting bridges, prestige signals, and "up or out" culture (Chapter 10)

EXCLUSIVE BONUSES INCLUDED:

BONUS #1: Strategic Due Diligence Checklist The complete 8-point framework VCs and CorpDev teams use to evaluate life science investments. Covers scientific validation, IP analysis, regulatory pathway, CMC risks, competitive landscape, management assessment, financials, and valuation calculations. This is your field manual for finding red flags in pitch decks.

BONUS #2: Real VC Case Study - NeuroSynthetix Practice with an actual interview case study used by life science VC firms. Analyze Phase 1b data, assess technical risks, define commercial strategy, and make a Go/No-Go recommendation (just like you will in your Superday interview) . Includes the complete scenario, data package, and framework for structured analysis. You can then book a time with me to go through it!

Perfect for:

• PhDs and MDs targeting venture capital roles
• Scientists exploring business development in pharma/biotech
• Researchers interested in corporate strategy and M&A
• Postdocs ready to transition from lab to investment side
• Anyone wanting to understand life science commercialization

You'll learn:

• How to evaluate drug assets like an investor (not a researcher)
• The mathematics VCs use to value companies and calculate returns
• What "Freedom to Operate," "Target Product Profile," and "rNPV" actually mean
• How to conduct technical due diligence that identifies deal-killers
• Which educational credentials (MBA, CFA) matter most for each path
• Real networking strategies that get you informational interviews with VCs

This isn't generic career advice—this is the strategic playbook used by PhDs who've successfully transitioned to the investment and deal-making side of life sciences.

Your PhD is a due diligence engine. Learn how to deploy it where it's worth millions.

Download now and start your strategic transition today.